Grant: Discovery Grants Program - Individual
University of Ottawa
$35,000.00
Characterization of the dedifferentiation process induced by newt regeneration derived extracts
EF 2009-10
Résumé
The newt, Notophthalmus viridescens, has the ability to regenerate structures (eg. limbs, tail, spinal cord, lens) which are lost to injury or amputation. Cells at the site of the injury revert back to an embryonic type of cell that can then proliferate and switch fate to rebuild the lost structure. This process, called dedifferentiation, is one of the keys to the regeneration process, and understanding the molecular basis behind dedifferentiation could help to enhance regenerative potential in humans. Studies have shown that mammalian muscle cells, when treated with newt regeneration extracts, re-enter the cell cycle and break-up from their multinucleated structures to yield proliferating mononuclear cells. This process is not very efficient, however, and many of the cells undergo cell death in the process. The aim of the current research proposal is to study the dedifferentiation process in newt cells in order to better understand how to improve dedifferentiation and regeneration in humans. We will study newt A1 muscle cells in culture that have been induced to dedifferentiate by adding serum to the medium or by treatment with newt-derived extracts. We will use a technique called Representational Difference Analysis (RDA) to isolate and characterize genes with potential regulatory roles during the newt dedifferentiation process. We present a comprehensive strategy for the isolation, prioritization and analysis of candidate genes with regulatory roles in the dedifferentiation process. We will 1) Conduct RDA on cell lines to identify dedifferentiation-initiating candidate genes, 2) Prioritize cDNAs to identify relevant candidates and 3) Perform functional analysis of candidate genes in regeneration. An understanding of the mechanisms involved in dedifferentiation will have tremendous therapeutic applications in degenerative disease and in neuronal injury.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
171259-2008
Name nom
Tsilfidis, Catherine
Department département
Cellular and Molecular Medicine
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2008
Award amount
35000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
33
Committee name en
Molec. & Develop. Genetics
Committee name fr
Gén. moléculaire et dévelop.
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5105
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell differentiation
Research subject fr
Différenciation cellulaire
Partie
2
Nb partie
5
Application title
Characterization of the dedifferentiation process induced by newt regeneration derived extracts
Keyword
NA
Application summary
The newt, Notophthalmus viridescens, has the ability to regenerate structures (eg. limbs, tail, spinal cord, lens) which are lost to injury or amputation. Cells at the site of the injury revert back to an embryonic type of cell that can then proliferate and switch fate to rebuild the lost structure. This process, called dedifferentiation, is one of the keys to the regeneration process, and understanding the molecular basis behind dedifferentiation could help to enhance regenerative potential in humans. Studies have shown that mammalian muscle cells, when treated with newt regeneration extracts, re-enter the cell cycle and break-up from their multinucleated structures to yield proliferating mononuclear cells. This process is not very efficient, however, and many of the cells undergo cell death in the process. The aim of the current research proposal is to study the dedifferentiation process in newt cells in order to better understand how to improve dedifferentiation and regeneration in humans. We will study newt A1 muscle cells in culture that have been induced to dedifferentiate by adding serum to the medium or by treatment with newt-derived extracts. We will use a technique called Representational Difference Analysis (RDA) to isolate and characterize genes with potential regulatory roles during the newt dedifferentiation process. We present a comprehensive strategy for the isolation, prioritization and analysis of candidate genes with regulatory roles in the dedifferentiation process. We will 1) Conduct RDA on cell lines to identify dedifferentiation-initiating candidate genes, 2) Prioritize cDNAs to identify relevant candidates and 3) Perform functional analysis of candidate genes in regeneration. An understanding of the mechanisms involved in dedifferentiation will have tremendous therapeutic applications in degenerative disease and in neuronal injury.